The Oncology Institute, Inc.
TOI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $28 | $30 | $40 | $50 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $60 | $56 | $50 | $49 |
| Inventory | $19 | $16 | $12 | $10 |
| Other Curr. Assets | $4 | $3 | $5 | $4 |
| Total Curr. Assets | $110 | $105 | $107 | $112 |
| Property Plant & Equip (Net) | $34 | $35 | $35 | $38 |
| Goodwill | $7 | $7 | $7 | $7 |
| Intangibles | $12 | $12 | $14 | $15 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $54 | $55 | $57 | $60 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $164 | $160 | $164 | $173 |
| Liabilities | – | – | – | – |
| Payables | $36 | $35 | $29 | $24 |
| Short-Term Debt | $7 | $7 | $7 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $4 | $5 |
| Other Curr. Liab. | $23 | $23 | $19 | $16 |
| Total Curr. Liab. | $66 | $65 | $60 | $52 |
| LT Debt | $20 | $96 | $95 | $116 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $90 | $8 | $4 | $1 |
| Total NC Liab. | $110 | $104 | $99 | $117 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $28 | $28 | $30 |
| Total Liabilities | $176 | $169 | $159 | $169 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$264 | -$247 | -$230 | -$211 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $252 | $238 | $235 | $214 |
| Total Equity | -$12 | -$9 | $5 | $4 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $164 | $160 | $164 | $173 |
| Net Debt | -$0 | $73 | $63 | $73 |